This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Quantifying Atherogenic Lipoproteins

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative

Publication in full

Authors

Michel R. Langlois, M. John Chapman, Christa Cobbaert, Samia Mora, Alan T. Remaley, Emilio Ros, Gerald F. Watts, Jan Borén, Hannsjörg Baum, Eric Bruckert, Alberico Catapano, Olivier S. Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Anne Langsted, Kari Pulkki, Nader Rifai, Grazyna Sypniewska, Olov Wiklund, Børge G. Nordestgaard

Editorial

New Joint Consensus Initiative on Quantifying Atherogenic Lipoproteins by  Jane K. Stock

Membership Software Powered by YourMembership  ::  Legal